Petaurus breviceps papuanus (sugar glider): 138142603
Help
Entry
138142603 CDS
T10505
Symbol
MAPK3
Name
(RefSeq) mitogen-activated protein kinase 3 isoform X1
KO
K04371
mitogen-activated protein kinase 1/3 [EC:
2.7.11.24
]
Organism
pbrv Petaurus breviceps papuanus (sugar glider)
Pathway
pbrv01521
EGFR tyrosine kinase inhibitor resistance
pbrv01522
Endocrine resistance
pbrv01524
Platinum drug resistance
pbrv04010
MAPK signaling pathway
pbrv04012
ErbB signaling pathway
pbrv04014
Ras signaling pathway
pbrv04015
Rap1 signaling pathway
pbrv04022
cGMP-PKG signaling pathway
pbrv04024
cAMP signaling pathway
pbrv04062
Chemokine signaling pathway
pbrv04066
HIF-1 signaling pathway
pbrv04068
FoxO signaling pathway
pbrv04071
Sphingolipid signaling pathway
pbrv04072
Phospholipase D signaling pathway
pbrv04114
Oocyte meiosis
pbrv04140
Autophagy - animal
pbrv04148
Efferocytosis
pbrv04150
mTOR signaling pathway
pbrv04151
PI3K-Akt signaling pathway
pbrv04210
Apoptosis
pbrv04218
Cellular senescence
pbrv04261
Adrenergic signaling in cardiomyocytes
pbrv04270
Vascular smooth muscle contraction
pbrv04350
TGF-beta signaling pathway
pbrv04360
Axon guidance
pbrv04370
VEGF signaling pathway
pbrv04371
Apelin signaling pathway
pbrv04380
Osteoclast differentiation
pbrv04510
Focal adhesion
pbrv04520
Adherens junction
pbrv04540
Gap junction
pbrv04550
Signaling pathways regulating pluripotency of stem cells
pbrv04611
Platelet activation
pbrv04613
Neutrophil extracellular trap formation
pbrv04620
Toll-like receptor signaling pathway
pbrv04621
NOD-like receptor signaling pathway
pbrv04625
C-type lectin receptor signaling pathway
pbrv04650
Natural killer cell mediated cytotoxicity
pbrv04657
IL-17 signaling pathway
pbrv04658
Th1 and Th2 cell differentiation
pbrv04659
Th17 cell differentiation
pbrv04660
T cell receptor signaling pathway
pbrv04662
B cell receptor signaling pathway
pbrv04664
Fc epsilon RI signaling pathway
pbrv04666
Fc gamma R-mediated phagocytosis
pbrv04668
TNF signaling pathway
pbrv04713
Circadian entrainment
pbrv04720
Long-term potentiation
pbrv04722
Neurotrophin signaling pathway
pbrv04723
Retrograde endocannabinoid signaling
pbrv04724
Glutamatergic synapse
pbrv04725
Cholinergic synapse
pbrv04726
Serotonergic synapse
pbrv04730
Long-term depression
pbrv04810
Regulation of actin cytoskeleton
pbrv04910
Insulin signaling pathway
pbrv04912
GnRH signaling pathway
pbrv04914
Progesterone-mediated oocyte maturation
pbrv04915
Estrogen signaling pathway
pbrv04916
Melanogenesis
pbrv04917
Prolactin signaling pathway
pbrv04919
Thyroid hormone signaling pathway
pbrv04921
Oxytocin signaling pathway
pbrv04926
Relaxin signaling pathway
pbrv04928
Parathyroid hormone synthesis, secretion and action
pbrv04929
GnRH secretion
pbrv04930
Type II diabetes mellitus
pbrv04933
AGE-RAGE signaling pathway in diabetic complications
pbrv04934
Cushing syndrome
pbrv04935
Growth hormone synthesis, secretion and action
pbrv04960
Aldosterone-regulated sodium reabsorption
pbrv05010
Alzheimer disease
pbrv05020
Prion disease
pbrv05022
Pathways of neurodegeneration - multiple diseases
pbrv05034
Alcoholism
pbrv05132
Salmonella infection
pbrv05133
Pertussis
pbrv05135
Yersinia infection
pbrv05140
Leishmaniasis
pbrv05142
Chagas disease
pbrv05145
Toxoplasmosis
pbrv05152
Tuberculosis
pbrv05160
Hepatitis C
pbrv05161
Hepatitis B
pbrv05163
Human cytomegalovirus infection
pbrv05164
Influenza A
pbrv05165
Human papillomavirus infection
pbrv05166
Human T-cell leukemia virus 1 infection
pbrv05167
Kaposi sarcoma-associated herpesvirus infection
pbrv05170
Human immunodeficiency virus 1 infection
pbrv05171
Coronavirus disease - COVID-19
pbrv05200
Pathways in cancer
pbrv05203
Viral carcinogenesis
pbrv05205
Proteoglycans in cancer
pbrv05206
MicroRNAs in cancer
pbrv05207
Chemical carcinogenesis - receptor activation
pbrv05208
Chemical carcinogenesis - reactive oxygen species
pbrv05210
Colorectal cancer
pbrv05211
Renal cell carcinoma
pbrv05212
Pancreatic cancer
pbrv05213
Endometrial cancer
pbrv05214
Glioma
pbrv05215
Prostate cancer
pbrv05216
Thyroid cancer
pbrv05218
Melanoma
pbrv05219
Bladder cancer
pbrv05220
Chronic myeloid leukemia
pbrv05221
Acute myeloid leukemia
pbrv05223
Non-small cell lung cancer
pbrv05224
Breast cancer
pbrv05225
Hepatocellular carcinoma
pbrv05226
Gastric cancer
pbrv05230
Central carbon metabolism in cancer
pbrv05231
Choline metabolism in cancer
pbrv05235
PD-L1 expression and PD-1 checkpoint pathway in cancer
pbrv05417
Lipid and atherosclerosis
Brite
KEGG Orthology (KO) [BR:
pbrv00001
]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
138142603 (MAPK3)
04012 ErbB signaling pathway
138142603 (MAPK3)
04014 Ras signaling pathway
138142603 (MAPK3)
04015 Rap1 signaling pathway
138142603 (MAPK3)
04350 TGF-beta signaling pathway
138142603 (MAPK3)
04370 VEGF signaling pathway
138142603 (MAPK3)
04371 Apelin signaling pathway
138142603 (MAPK3)
04668 TNF signaling pathway
138142603 (MAPK3)
04066 HIF-1 signaling pathway
138142603 (MAPK3)
04068 FoxO signaling pathway
138142603 (MAPK3)
04072 Phospholipase D signaling pathway
138142603 (MAPK3)
04071 Sphingolipid signaling pathway
138142603 (MAPK3)
04024 cAMP signaling pathway
138142603 (MAPK3)
04022 cGMP-PKG signaling pathway
138142603 (MAPK3)
04151 PI3K-Akt signaling pathway
138142603 (MAPK3)
04150 mTOR signaling pathway
138142603 (MAPK3)
09140 Cellular Processes
09141 Transport and catabolism
04140 Autophagy - animal
138142603 (MAPK3)
04148 Efferocytosis
138142603 (MAPK3)
09143 Cell growth and death
04114 Oocyte meiosis
138142603 (MAPK3)
04210 Apoptosis
138142603 (MAPK3)
04218 Cellular senescence
138142603 (MAPK3)
09144 Cellular community - eukaryotes
04510 Focal adhesion
138142603 (MAPK3)
04520 Adherens junction
138142603 (MAPK3)
04540 Gap junction
138142603 (MAPK3)
04550 Signaling pathways regulating pluripotency of stem cells
138142603 (MAPK3)
09142 Cell motility
04810 Regulation of actin cytoskeleton
138142603 (MAPK3)
09150 Organismal Systems
09151 Immune system
04611 Platelet activation
138142603 (MAPK3)
04613 Neutrophil extracellular trap formation
138142603 (MAPK3)
04620 Toll-like receptor signaling pathway
138142603 (MAPK3)
04621 NOD-like receptor signaling pathway
138142603 (MAPK3)
04625 C-type lectin receptor signaling pathway
138142603 (MAPK3)
04650 Natural killer cell mediated cytotoxicity
138142603 (MAPK3)
04660 T cell receptor signaling pathway
138142603 (MAPK3)
04658 Th1 and Th2 cell differentiation
138142603 (MAPK3)
04659 Th17 cell differentiation
138142603 (MAPK3)
04657 IL-17 signaling pathway
138142603 (MAPK3)
04662 B cell receptor signaling pathway
138142603 (MAPK3)
04664 Fc epsilon RI signaling pathway
138142603 (MAPK3)
04666 Fc gamma R-mediated phagocytosis
138142603 (MAPK3)
04062 Chemokine signaling pathway
138142603 (MAPK3)
09152 Endocrine system
04910 Insulin signaling pathway
138142603 (MAPK3)
04929 GnRH secretion
138142603 (MAPK3)
04912 GnRH signaling pathway
138142603 (MAPK3)
04915 Estrogen signaling pathway
138142603 (MAPK3)
04914 Progesterone-mediated oocyte maturation
138142603 (MAPK3)
04917 Prolactin signaling pathway
138142603 (MAPK3)
04921 Oxytocin signaling pathway
138142603 (MAPK3)
04926 Relaxin signaling pathway
138142603 (MAPK3)
04935 Growth hormone synthesis, secretion and action
138142603 (MAPK3)
04919 Thyroid hormone signaling pathway
138142603 (MAPK3)
04928 Parathyroid hormone synthesis, secretion and action
138142603 (MAPK3)
04916 Melanogenesis
138142603 (MAPK3)
09153 Circulatory system
04261 Adrenergic signaling in cardiomyocytes
138142603 (MAPK3)
04270 Vascular smooth muscle contraction
138142603 (MAPK3)
09155 Excretory system
04960 Aldosterone-regulated sodium reabsorption
138142603 (MAPK3)
09156 Nervous system
04724 Glutamatergic synapse
138142603 (MAPK3)
04725 Cholinergic synapse
138142603 (MAPK3)
04726 Serotonergic synapse
138142603 (MAPK3)
04720 Long-term potentiation
138142603 (MAPK3)
04730 Long-term depression
138142603 (MAPK3)
04723 Retrograde endocannabinoid signaling
138142603 (MAPK3)
04722 Neurotrophin signaling pathway
138142603 (MAPK3)
09158 Development and regeneration
04360 Axon guidance
138142603 (MAPK3)
04380 Osteoclast differentiation
138142603 (MAPK3)
09159 Environmental adaptation
04713 Circadian entrainment
138142603 (MAPK3)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
138142603 (MAPK3)
05206 MicroRNAs in cancer
138142603 (MAPK3)
05205 Proteoglycans in cancer
138142603 (MAPK3)
05207 Chemical carcinogenesis - receptor activation
138142603 (MAPK3)
05208 Chemical carcinogenesis - reactive oxygen species
138142603 (MAPK3)
05203 Viral carcinogenesis
138142603 (MAPK3)
05230 Central carbon metabolism in cancer
138142603 (MAPK3)
05231 Choline metabolism in cancer
138142603 (MAPK3)
05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
138142603 (MAPK3)
09162 Cancer: specific types
05210 Colorectal cancer
138142603 (MAPK3)
05212 Pancreatic cancer
138142603 (MAPK3)
05225 Hepatocellular carcinoma
138142603 (MAPK3)
05226 Gastric cancer
138142603 (MAPK3)
05214 Glioma
138142603 (MAPK3)
05216 Thyroid cancer
138142603 (MAPK3)
05221 Acute myeloid leukemia
138142603 (MAPK3)
05220 Chronic myeloid leukemia
138142603 (MAPK3)
05218 Melanoma
138142603 (MAPK3)
05211 Renal cell carcinoma
138142603 (MAPK3)
05219 Bladder cancer
138142603 (MAPK3)
05215 Prostate cancer
138142603 (MAPK3)
05213 Endometrial cancer
138142603 (MAPK3)
05224 Breast cancer
138142603 (MAPK3)
05223 Non-small cell lung cancer
138142603 (MAPK3)
09172 Infectious disease: viral
05166 Human T-cell leukemia virus 1 infection
138142603 (MAPK3)
05170 Human immunodeficiency virus 1 infection
138142603 (MAPK3)
05161 Hepatitis B
138142603 (MAPK3)
05160 Hepatitis C
138142603 (MAPK3)
05171 Coronavirus disease - COVID-19
138142603 (MAPK3)
05164 Influenza A
138142603 (MAPK3)
05163 Human cytomegalovirus infection
138142603 (MAPK3)
05167 Kaposi sarcoma-associated herpesvirus infection
138142603 (MAPK3)
05165 Human papillomavirus infection
138142603 (MAPK3)
09171 Infectious disease: bacterial
05132 Salmonella infection
138142603 (MAPK3)
05135 Yersinia infection
138142603 (MAPK3)
05133 Pertussis
138142603 (MAPK3)
05152 Tuberculosis
138142603 (MAPK3)
09174 Infectious disease: parasitic
05145 Toxoplasmosis
138142603 (MAPK3)
05140 Leishmaniasis
138142603 (MAPK3)
05142 Chagas disease
138142603 (MAPK3)
09164 Neurodegenerative disease
05010 Alzheimer disease
138142603 (MAPK3)
05020 Prion disease
138142603 (MAPK3)
05022 Pathways of neurodegeneration - multiple diseases
138142603 (MAPK3)
09165 Substance dependence
05034 Alcoholism
138142603 (MAPK3)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
138142603 (MAPK3)
09167 Endocrine and metabolic disease
04930 Type II diabetes mellitus
138142603 (MAPK3)
04933 AGE-RAGE signaling pathway in diabetic complications
138142603 (MAPK3)
04934 Cushing syndrome
138142603 (MAPK3)
09176 Drug resistance: antineoplastic
01521 EGFR tyrosine kinase inhibitor resistance
138142603 (MAPK3)
01524 Platinum drug resistance
138142603 (MAPK3)
01522 Endocrine resistance
138142603 (MAPK3)
09180 Brite Hierarchies
09181 Protein families: metabolism
01001 Protein kinases [BR:
pbrv01001
]
138142603 (MAPK3)
09182 Protein families: genetic information processing
03036 Chromosome and associated proteins [BR:
pbrv03036
]
138142603 (MAPK3)
09183 Protein families: signaling and cellular processes
04147 Exosome [BR:
pbrv04147
]
138142603 (MAPK3)
Enzymes [BR:
pbrv01000
]
2. Transferases
2.7 Transferring phosphorus-containing groups
2.7.11 Protein-serine/threonine kinases
2.7.11.24 mitogen-activated protein kinase
138142603 (MAPK3)
Protein kinases [BR:
pbrv01001
]
Serine/threonine kinases: CMGC group
MAPK family [OT]
138142603 (MAPK3)
Chromosome and associated proteins [BR:
pbrv03036
]
Eukaryotic type
Centromeric chromatin formation proteins
SAC (spindle assembly checkpoint) factors
Protein kinases
138142603 (MAPK3)
Exosome [BR:
pbrv04147
]
Exosomal proteins
Exosomal proteins of haemopoietic cells (B-cell, T-cell, DC-cell, reticulocyte, and mast cell)
138142603 (MAPK3)
BRITE hierarchy
SSDB
Ortholog
Paralog
GFIT
Motif
Pfam:
Pkinase
PK_Tyr_Ser-Thr
ABC1
APH
Haspin_kinase
FTA2
Kdo
Lant_dehydr_N
Motif
Other DBs
NCBI-GeneID:
138142603
NCBI-ProteinID:
XP_068919807
LinkDB
All DBs
Position
Unknown
AA seq
356 aa
AA seq
DB search
MFREGRGPWGSSTGGEGSPEIFLGKGGSPGYNLSSAFDHVQKARVAIKKISPFEHQTYCQ
RTLREIQILLRCHHENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHV
CYFLYQILRGLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTE
YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS
PSQDDLNCIINMKARNYLQSLPSKPKVPWVKLFPKADPKALDLLDRMLTFNPNKRITVED
ALAHPYLEQYYDPTDEPVAEEPFTFDMELDDLPKERLKELIFQETAQFQPGAPGAP
NT seq
1071 nt
NT seq
+upstream
nt +downstream
nt
atgttcagggaaggaagagggccctggggaagttccaccggaggggaggggtctccagag
atattcttagggaagggagggagcccaggatacaatctgagctctgcctttgatcatgtg
cagaaggcccgagtagccatcaagaagatcagcccatttgagcaccagacatattgccag
cgcaccctacgagagattcagatcctgcttcgctgccaccatgaaaatgtcattggcatt
cgtgacatccttcgagcatccacactggaggccatgagggatgtctacattgttcaggac
ctgatggaaacagacttgtataagctgctcaagagccagcagctgagtaatgaccatgtc
tgctacttcctctaccaaattcttcggggcctcaaatatatccactcagccaatgtactc
catcgggacctcaaaccctccaatctgctcattaacactacttgtgacctcaagatctgt
gactttggcctggcccgaattgctgaccctgagcacgatcacacaggcttcctgaccgag
tatgtggctacccgctggtatagagcaccagagatcatgctcaattccaagggctatacc
aaatccatcgatatctggtctgtgggctgtatcctcgcggaaatgctctccaatcgtccc
atcttccctgggaagcactacctggaccagttgaaccacattctaggtatcctgggttct
ccatctcaggatgatctgaattgtatcatcaacatgaaggcccggaactacctgcagtcc
cttccatccaagcctaaggtgccctgggtcaagctctttcccaaagcagatcccaaagcc
ctggacctgctggaccggatgttgacctttaaccccaacaagcgaatcacagtggaggat
gccctggcccatccctacttggagcagtactatgatccaactgatgagccagtggcagaa
gaaccctttacctttgacatggagctggatgacctgccaaaggaacgactgaaggagctc
atcttccaagagacagcccaattccaacctggagccccaggagccccctga
DBGET
integrated database retrieval system